Canon Medical Systems Corporation, headquartered in Japan, is a leading player in the medical imaging and healthcare technology industry. Founded in 2003, the company has rapidly evolved, establishing a strong presence in regions such as North America, Europe, and Asia. Specialising in advanced imaging solutions, Canon Medical offers a diverse range of products, including CT, MRI, ultrasound, and X-ray systems. Their commitment to innovation is evident in their unique technologies that enhance diagnostic accuracy and patient care. With a reputation for quality and reliability, Canon Medical has achieved significant milestones, positioning itself as a trusted partner in healthcare. The company continues to push the boundaries of medical imaging, contributing to improved clinical outcomes worldwide.
How does Canon Medical Systems Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Canon Medical Systems Corporation's score of 51 is higher than 71% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, Canon Medical Systems Corporation reported total carbon emissions of approximately 977,000 kg CO2e. This includes Scope 1 emissions of about 633,000 kg CO2e, Scope 2 emissions of around 344,000 kg CO2e, and Scope 3 emissions totalling approximately 156,000 kg CO2e. Within Scope 3, significant contributors were business travel (156,000 kg CO2e) and downstream transportation and distribution (98,000 kg CO2e). Canon Medical Systems has set ambitious climate commitments, aiming for a 42% reduction in Scope 1 and Scope 2 emissions from 2022 levels by 2030. Additionally, the company has pledged to achieve net-zero emissions across all scopes by 2045. These targets are part of a broader sustainability strategy inherited from its parent company, Canon Inc., which also influences its climate initiatives. The emissions data and reduction targets reflect Canon Medical Systems' commitment to addressing climate change and reducing its carbon footprint in the medical technology sector.
Access structured emissions data, company-specific emission factors, and source documents
| 2023 | |
|---|---|
| Scope 1 | 633,000 |
| Scope 2 | 344,000 |
| Scope 3 | 156,000 |
Their carbon footprint includes suppliers and value chain emissions, with Scope 3 emissions accounting for 14% of total emissions under the GHG Protocol, with "Business Travel" being the largest emissions source at 100% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Canon Medical Systems Corporation has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.